Abstract
Screening mammography is recommended by U.S. medical organizations for breast cancer screening in average risk women because of its demonstrated reductions in breast cancer mortality. However, significant disparities in breast cancer screening utilization and mortality remain among racial/ethnic minorities. Efforts have appropriately been directed at increasing engagement with screening services in these populations, however, there is a dearth of data regarding false-positive rates and overdiagnosis in minority patients engaged in breast cancer screening. We recently examined screening practices among a predominantly Hispanic population presenting to an academic medical center in New York, NY, and found that approximately 53% of women experienced at least one false-positive mammography result over a median of 8.9 years of screening. We also observed that Hispanic women were more likely to screen annually than white women despite recommendations to screen less frequently. In this review, we briefly review the benefits and harms of screening mammography in average-risk women, namely, false-positive results and breast cancer overdiagnosis, followed by a discussion of the disparities in breast cancer screening and mortality among racial/ethnic minority populations. We then present our own recent observations and propose that future interventions among Hispanic and other minority populations could include patient- and provider-centered educational programs that focus on providing a balanced discussion of benefits and harms of screening mammography.
Highlights
While the benefits of screening mammography are almost universally accepted by healthcare professionals, in recent years there has been an increasing focus on the potential physical, psychological, and financial harms of mammography
Efforts have appropriately been directed at increasing engagement with screening services in these populations, there is a dearth of data regarding false-positive rates and overdiagnosis in minority patients engaged in breast cancer screening
We recently examined screening practices among a predominantly Hispanic population presenting to an academic medical center in New York, NY, and found that approximately 53% of women experienced at least one false-positive mammography result over a median of 8.9 years of screening
Summary
Breast Cancer Risk Assessment and Screening in Average-Risk Women. National expenditure for false-positive mammograms and breast cancer overdiagnoses estimated at $4 billion a year. Coughlin SS, Leadbetter S, Richards T, et al Contextual analysis of breast and cervical cancer screening and factors associated with health care access among United States women, 2002. Tangka FK, Subramanian S, Mobley LR, et al Racial and ethnic disparities among state Medicaid programs for breast cancer screening. DeSantis CE, Ma J, Goding Sauer A, et al Breast cancer statistics, 2017, racial disparity in mortality by state. The National Breast and Cervical Cancer Early Detection Program: a comprehensive public health response to two major health issues for women.
Published Version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have